MC
CLB icon

Middleton & Co’s Core Laboratories CLB Stock Holding History

Middleton & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,220
Closed -$441K – 153
2014
Q1 		$441K Sell
2,220
-530
-19% -$100K 0.1% 118
2013
Q4 		$525K Hold
2,750
– – 0.14% 96
2013
Q3 		$465K Hold
2,750
– – 0.12% 111
2013
Q2 		$418K Buy
+2,750
New +$390K 0.12% 108

Other funds holding CLB

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Middleton & Co's CLB Position: Q2 2014 in Review

Middleton & Co sold out of Core Laboratories (CLB) in Q2 2014, closing a stake of 2,220 shares — an estimated $441K sold.

Middleton & Co first reported a position in CLB in Q2 2013 and held it in 4 quarters. The position peaked at $525K in Q4 2013. 346 funds tracked by Wall St. Rank hold CLB as of Q2 2014.

  • Middleton & Co reported no remaining Core Laboratories position as of Q2 2014 after selling out during the quarter.
  • Middleton & Co sold 2,220 Core Laboratories shares in Q2 2014, an estimated $441K.
  • Middleton & Co first reported a position in Core Laboratories in Q2 2013 and held it in 4 quarters.
  • Middleton & Co's Core Laboratories position peaked at $525K in Q4 2013.
  • 346 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2014.

Based on Middleton & Co's 13F filing for Q2 2014, filed 24 Jul 2014.